SEI Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.1M Sell
85,055
-43,559
-34% -$10.9M 0.02% 805
2025
Q4
$31M Sell
128,614
-21,044
-14% -$5.38M 0.03% 562
2025
Q3
$41M Buy
149,658
+3,745
+3% +$1.02M 0.04% 440
2025
Q2
$37.6M Sell
145,913
-20,195
-12% -$4.82M 0.04% 441
2025
Q1
$37.2M Buy
166,108
+12,583
+8% +$2.94M 0.05% 416
2024
Q4
$35.1M Buy
153,525
+115,192
+301% +$27.7M 0.05% 431
2024
Q3
$9.36M Buy
38,333
+1,832
+5% +$409K 0.01% 1018
2024
Q2
$6.99M Buy
36,501
+14,793
+68% +$3M 0.01% 1079
2024
Q1
$4.3M Buy
21,708
+2,484
+13% +$455K 0.01% 1276
2023
Q4
$3.31M Buy
19,224
+2,324
+14% +$357K 0.01% 1374
2023
Q3
$2.5M Sell
16,900
-17,128
-50% -$3.1M ﹤0.01% 1492
2023
Q2
$7.44M Buy
34,028
+1,332
+4% +$297K 0.01% 1021
2023
Q1
$7.16M Buy
32,696
+8,168
+33% +$1.77M 0.01% 1016
2022
Q4
$5.11M Sell
24,528
-11,821
-33% -$2.6M 0.01% 1043
2022
Q3
$7.93M Buy
36,349
+505
+1% +$115K 0.02% 872
2022
Q2
$7.46M Sell
35,844
-4,896
-12% -$1.04M 0.02% 913
2022
Q1
$9.78M Buy
40,740
+2,955
+8% +$715K 0.02% 785
2021
Q4
$9.94M Sell
37,785
-1,448
-4% -$376K 0.02% 793
2021
Q3
$10.4M Buy
39,233
+5,329
+16% +$1.46M 0.02% 723
2021
Q2
$8.27M Sell
33,904
-43,693
-56% -$9.19M 0.02% 829
2021
Q1
$15.1M Buy
77,597
+18,791
+32% +$3.77M 0.04% 483
2020
Q4
$12.5M Sell
58,806
-15,323
-21% -$3.06M 0.03% 538
2020
Q3
$12.7M Buy
74,129
+24,584
+50% +$4.54M 0.04% 451
2020
Q2
$9.53M Buy
49,545
+14,573
+42% +$2.38M 0.03% 565
2020
Q1
$5.15M Buy
34,972
+5,041
+17% +$803K 0.02% 746
2019
Q4
$4.64M Buy
29,931
+10,317
+53% +$1.49M 0.01% 951
2019
Q3
$2.65M Sell
19,614
-41,164
-68% -$5.39M 0.01% 1207
2019
Q2
$7.42M Sell
60,778
-42,380
-41% -$4.69M 0.02% 730
2019
Q1
$10.7M Buy
103,158
+56,442
+121% +$5.83M 0.04% 522
2018
Q4
$5.4M Buy
46,716
+901
+2% +$96.5K 0.02% 857
2018
Q3
$5.29M Sell
45,815
-28,816
-39% -$3.16M 0.02% 834
2018
Q2
$7.73M Buy
74,631
+46,408
+164% +$4.7M 0.03% 708
2018
Q1
$2.78M Buy
28,223
+8,813
+45% +$833K 0.01% 1085
2017
Q4
$1.65M Buy
19,410
+1,719
+10% +$142K 0.01% 1356
2017
Q3
$1.36M Buy
17,691
+14,245
+413% +$1.09M ﹤0.01% 1363
2017
Q2
$268K Sell
3,446
-3,371
-49% -$241K ﹤0.01% 1805
2017
Q1
$490K Buy
6,817
+4,993
+274% +$345K ﹤0.01% 1587
2016
Q4
$113K Sell
1,824
-348
-16% -$21.3K ﹤0.01% 1931
2016
Q3
$141K Buy
2,172
+450
+26% +$30K ﹤0.01% 1780
2016
Q2
$109K Buy
1,722
+450
+35% +$26.5K ﹤0.01% 1714
2016
Q1
$74K Buy
1,272
+349
+38% +$19.8K ﹤0.01% 1745
2015
Q4
$50K Buy
923
+603
+188% +$34K ﹤0.01% 1893
2015
Q3
$17K Sell
320
-4
-1% -$215 ﹤0.01% 2085
2015
Q2
$19K Sell
324
-2
-0.6% -$126 ﹤0.01% 1815
2015
Q1
$22K Sell
326
-8
-2% -$520 ﹤0.01% 1795
2014
Q4
$20K Buy
+334
New +$17.4K ﹤0.01% 1808

Other funds holding RMD

SEI Investments's RMD Position: Q1 2026 in Review

SEI Investments reduced its ResMed (RMD) stake by 34% in Q1 2026, selling an estimated $10.9M and leaving 85,055 shares worth $19.1M. The position accounts for 0.02% of the portfolio, ranked #805.

SEI Investments first reported a position in RMD in Q4 2014 and has held it in 46 quarters since. The position peaked at $41M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • SEI Investments held 85,055 shares of ResMed worth $19.1M as of Q1 2026.
  • SEI Investments sold 43,559 ResMed shares in Q1 2026, an estimated $10.9M.
  • ResMed made up 0.02% of SEI Investments's portfolio in Q1 2026, its #805 holding.
  • SEI Investments first reported a position in ResMed in Q4 2014 and has held it in 46 quarters since.
  • SEI Investments's ResMed position peaked at $41M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.